These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

577 related articles for article (PubMed ID: 26601932)

  • 1. SUMOylation-Mediated Regulation of Cell Cycle Progression and Cancer.
    Eifler K; Vertegaal ACO
    Trends Biochem Sci; 2015 Dec; 40(12):779-793. PubMed ID: 26601932
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sumoylation and Its Contribution to Cancer.
    Lee JS; Choi HJ; Baek SH
    Adv Exp Med Biol; 2017; 963():283-298. PubMed ID: 28197919
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting SUMO Signaling to Wrestle Cancer.
    Kroonen JS; Vertegaal ACO
    Trends Cancer; 2021 Jun; 7(6):496-510. PubMed ID: 33353838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Small-Molecule Inhibitors Targeting Protein SUMOylation as Novel Anticancer Compounds.
    Yang Y; Xia Z; Wang X; Zhao X; Sheng Z; Ye Y; He G; Zhou L; Zhu H; Xu N; Liang S
    Mol Pharmacol; 2018 Aug; 94(2):885-894. PubMed ID: 29784649
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell cycle-dependent conjugation of endogenous BRCA1 protein with SUMO-2/3.
    Vialter A; Vincent A; Demidem A; Morvan D; Stepien G; Venezia ND; Rio PG
    Biochim Biophys Acta; 2011 Apr; 1810(4):432-8. PubMed ID: 21147198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The post-translational modification, SUMOylation, and cancer (Review).
    Han ZJ; Feng YH; Gu BH; Li YM; Chen H
    Int J Oncol; 2018 Apr; 52(4):1081-1094. PubMed ID: 29484374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Probing the roles of SUMOylation in cancer cell biology by using a selective SAE inhibitor.
    He X; Riceberg J; Soucy T; Koenig E; Minissale J; Gallery M; Bernard H; Yang X; Liao H; Rabino C; Shah P; Xega K; Yan ZH; Sintchak M; Bradley J; Xu H; Duffey M; England D; Mizutani H; Hu Z; Guo J; Chau R; Dick LR; Brownell JE; Newcomb J; Langston S; Lightcap ES; Bence N; Pulukuri SM
    Nat Chem Biol; 2017 Nov; 13(11):1164-1171. PubMed ID: 28892090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The emerging roles of SUMOylation in pulmonary diseases.
    Zheng X; Wang L; Zhang Z; Tang H
    Mol Med; 2023 Sep; 29(1):119. PubMed ID: 37670258
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of small ubiquitin-like modifier substrates with diverse functions using the Xenopus egg extract system.
    Ma L; Aslanian A; Sun H; Jin M; Shi Y; Yates JR; Hunter T
    Mol Cell Proteomics; 2014 Jul; 13(7):1659-75. PubMed ID: 24797264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell cycle-dependent SUMO-1 conjugation to nuclear mitotic apparatus protein (NuMA).
    Seo JS; Kim HN; Kim SJ; Bang J; Kim EA; Sung KS; Yoon HJ; Yoo HY; Choi CY
    Biochem Biophys Res Commun; 2014 Jan; 443(1):259-65. PubMed ID: 24309115
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of a new small ubiquitin-like modifier (SUMO)-interacting motif in the E3 ligase PIASy.
    Kaur K; Park H; Pandey N; Azuma Y; De Guzman RN
    J Biol Chem; 2017 Jun; 292(24):10230-10238. PubMed ID: 28455449
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Small ubiquitin-like modifiers in cellular malignancy and metastasis.
    Kim KI; Baek SH
    Int Rev Cell Mol Biol; 2009; 273():265-311. PubMed ID: 19215907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of the loss of SUMO pathway function on cancer cells and tumor proliferation.
    He X; Riceberg J; Pulukuri SM; Grossman S; Shinde V; Shah P; Brownell JE; Dick L; Newcomb J; Bence N
    PLoS One; 2015; 10(4):e0123882. PubMed ID: 25860128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. E2-mediated small ubiquitin-like modifier (SUMO) modification of thymine DNA glycosylase is efficient but not selective for the enzyme-product complex.
    Coey CT; Fitzgerald ME; Maiti A; Reiter KH; Guzzo CM; Matunis MJ; Drohat AC
    J Biol Chem; 2014 May; 289(22):15810-9. PubMed ID: 24753249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Converging Small Ubiquitin-like Modifier (SUMO) and Ubiquitin Signaling: Improved Methodology Identifies Co-modified Target Proteins.
    Cuijpers SAG; Willemstein E; Vertegaal ACO
    Mol Cell Proteomics; 2017 Dec; 16(12):2281-2295. PubMed ID: 28951443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mapping the SUMOylated landscape.
    Eifler K; Vertegaal AC
    FEBS J; 2015 Oct; 282(19):3669-80. PubMed ID: 26185901
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sumoylation on its 25th anniversary: mechanisms, pathology, and emerging concepts.
    Celen AB; Sahin U
    FEBS J; 2020 Aug; 287(15):3110-3140. PubMed ID: 32255256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SUMO in cancer--wrestlers wanted.
    Alarcon-Vargas D; Ronai Z
    Cancer Biol Ther; 2002; 1(3):237-42. PubMed ID: 12432270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The SUMO-specific protease family regulates cancer cell radiosensitivity.
    Hu C; Jiang X
    Biomed Pharmacother; 2019 Jan; 109():66-70. PubMed ID: 30396093
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DeSUMOylation: An Important Therapeutic Target and Protein Regulatory Event.
    Huang CJ; Wu D; Khan FA; Huo LJ
    DNA Cell Biol; 2015 Nov; 34(11):652-60. PubMed ID: 26309017
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.